[HTML] nih.gov

[HTML][HTML] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background ROS1 gene rearrangement has been reported in several types of cancers,
including non-small cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors …
被引用次数：6 相关文章

Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui… - Translational …, 2020 - pubmed.ncbi.nlm.nih.gov
Background ROS1 gene rearrangement has been reported in several types of cancers,
including non-small cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors …

Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis.

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo… - Translational Cancer …, 2020 - europepmc.org
Background ROS1 gene rearrangement has been reported in several types of cancers,
including non-small cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors …
[HTML] amegroups.org

[HTML][HTML] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo… - Translational Cancer …, 2020 - tcr.amegroups.org
Background: ROS1 gene rearrangement has been reported in several types of cancers,
including non-small cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors …
[PDF] researchgate.net

[PDF][PDF] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo, H Wang - 2020 - researchgate.net
Background: ROS1 gene rearrangement has been reported in several types of cancers,
including nonsmall cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors are …
[PDF] semanticscholar.org

[PDF][PDF] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo, H Wang - 2020 - pdfs.semanticscholar.org
Background: ROS1 gene rearrangement has been reported in several types of cancers,
including nonsmall cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors are …
[PDF] amegroups.cn

[PDF][PDF] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo, H Wang - 2020 - cdn.amegroups.cn
Background: ROS1 gene rearrangement has been reported in several types of cancers,
including nonsmall cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors are …

[引用][C] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo… - Translational Cancer …, 2020 - tcr.amegroups.org
Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung
cancer: a meta-analysis - Bi - Translational Cancer Research Have a website account?Log In …

Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis.

H Bi, D Ren, X Ding, X Yin, S Cui, C Guo… - Translational Cancer …, 2020 - europepmc.org
Background ROS1 gene rearrangement has been reported in several types of cancers,
including non-small cell lung cancer (NSCLC). It is reported that tyrosine kinase inhibitors …